StockTipsArenaBeta

BUY Eris Lifesciences Limited — BOB Capital Markets

BUYEris Lifesciences Limited
Eris Lifesciences share price target & all analyst calls

byBOB Capital MarketsHorizon: NA (inferred 1 year)15 Feb 2026via Institutional / Brokerage Research

Entry₹1,414.4Inferred
Target₹1,756
Total upside +24.15%
Stop lossNot given
CMP₹1,121.28h ago
Active-20.73%+56.62%upside left 4 mo left
Follow BOB Capital Markets for new calls(63% target hit, 357 closed calls)Get alertsWatch ERIS for new buy/sell callsGet alertsSee 4 other Long-term calls on ERISSee 214 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 23 Oct, 12:37 am IST
5 supporting9 neutral2 opposing
Supports the BUY call (5)

4 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·28 Aug · 2mo ago

Neutral / worth noting (9)

Q2 FY27 results scheduled — board meets 26 Oct 2026

BSE · Board Meeting·In 3 days

(opens in new tab)
Weighs against the BUY call (2)

Long-term trend bearish — 200-day average falling over the past quarter

Technicals · trend·22 Oct · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Eris Lifesciences

All analyst calls on Eris Lifesciences

More from BOB Capital Markets

Every call and its outcome